27% growth in prescriptions dispensed over prior quarter; 147% growth over comparable quarter in 2022. 5 consecutive quarters of double-digit growth. Click here to learn more ›
Episodic Efficacy With Subcutaneous Bremelanotide Self-administered at Home by Premenopausal Women With Female Sexual Dysfunction (FSD) as Measured by the Female Sexual Encounter Profile- Revised
